|Awarded On||August 16, 2023|
|Title||Implementation and Dissemination of an Evidence-Based Intervention to Increase Tobacco Treatment Capacity in Opioid Treatment Programs|
|Award Mechanism||Dissemination of CPRIT-Funded Cancer Control Interventions|
|Institution/Organization||The University of Texas M.D. Anderson Cancer Center|
|Principal Investigator/Program Director||Lorraine Reitzel|
*Pending contract negotiation
Tobacco use is causally linked to ~17 different cancers and remains the leading cause of death, disability, and disease. Although tobacco use has steadily declined in the general population, tobacco use rates among individuals with opioid use disorders (OUDs) has remained remarkably high (75%-95%). As such, individuals with OUDs are recognized as a priority population for tobacco control and intervention. Despite the heightened detrimental health effects of concurrent use of tobacco and opioids, as well as positive effects of tobacco cessation on OUD treatment outcomes, many OUD treatment programs (OTPs; i.e., one or more OUD treatment centers within the same organization) fail to prov...